TGFB1 and neoplasm: A crucial factor in defining the switch in the TGF-β1 signaling pathway from tumor suppression to fibrogenesis, which accelerates liver fibrosis and raises the risk for HCC, is also the persistence of chronic inflammation, as seen in chronic viral hepatitis.